GSK plc (GSK) Financials
GSK Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 75.2 billion | 58.9 billion |
2023-09-30 | 74.2 billion | 58.8 billion |
2023-06-30 | 75.1 billion | 59.7 billion |
2023-03-31 | 72.6 billion | 58.6 billion |
GSK Free Cash Flow and Stock based compensation
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | 2.8 billion | -3.0 billion |
2023-09-30 | 2.1 billion | ? |
2023-06-30 | 974.6 million | ? |
2023-03-31 | -589.8 million | ? |
GSK Net Income
Date | Net Income |
---|---|
2023-12-31 | 445.9 million |
2023-09-30 | 1.9 billion |
2023-06-30 | 2.2 billion |
2023-03-31 | 2.0 billion |
GSK Cash and Debt
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 6.6 billion | - | 1.5 billion |
2023-09-30 | 8.2 billion | 19.5 billion | - |
2023-06-30 | 8.2 billion | 19.6 billion | - |
2023-03-31 | 8.6 billion | 20.6 billion | - |
GSK Shares Outstanding
GSK Expenses
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 997.5 million | 2.6 billion | 3.4 billion | 82.8 million |
2023-09-30 | 606.2 million | 1.9 billion | 2.8 billion | - |
2023-06-30 | 675.4 million | 1.7 billion | 2.9 billion | - |
2023-03-31 | 655.4 million | 1.6 billion | 2.7 billion | - |
GSK Cost of Revenue
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 10.3 billion | 3.0 billion |
2023-09-30 | 9.9 billion | 2.8 billion |
2023-06-30 | 9.1 billion | 2.4 billion |
2023-03-31 | 8.6 billion | 2.4 billion |
GSK
Price: $43.50
Dividend Yield: 0.01%
Forward Dividend Yield: 3.73%
Payout Ratio: 54.15%
Dividend Per Share: 1.62 USD
Earnings Per Share: 2.73 USD
P/E Ratio: 13.80
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers - General
Volume: 3.7 million
Ebitda: 2.0 billionMarket Capitalization: 88.7 billion
Average Dividend Frequency: 3
Years Paying Dividends: 41
DGR3: -10.18%
DGR5: -7.21%
DGR10: -3.71%
DGR20: 1.60%